non executive director
Thomas brings a wealth of experience enabling the Dreamcity team to leverage upon the significant management, business, capital raising and portfolio development capabilities. Thomas is currently the Chief Executive Officer of Immuron, listed on ASX & NASDAQ and one of the Board Directors at PharmaCyte, a publicly listed company focused on developing and preparing to commercialize treatments for cancer and diabetes.
Thomas has decades of experience in various commercialization, product development and leadership roles with big pharmaceutical and biotech companies. His experience has been in successful portfolio development and engineering investment strategies for growth. In his successful career, he had led and been instrumental for multimillion dollar investment of acquisition projects including Pfizer in New York, Next Wave Pharmaceuticals and PharmaCyte.